Clinical Trials Browser

NCT02961101 2026-01-22

Anti-PD-1 Antibody Alone or in Combination With Decitabine/Chemotherapy in Relapsed or Refractory Malignancies

Phase 1/2 Recruiting

250 enrolled

Neoplasms, Recurrence

NCT06090864 2025-10-20

ATLCAR.CD30.CCR4 for CD30+ HL ATLCAR.CD30.CCR4 Cells

Phase 1/2 Recruiting

31 enrolled

Lymphoid

Hodgkin Disease, Recurrence

NCT03383094 2025-10-07

Chemoradiation vs Immunotherapy and Radiation for Head and Neck Cancer

Phase 2 Active not recruiting

126 enrolled

Head & Neck

Parkinson Disease 4, Autosomal Dominant Lewy Body, Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Mouth Neoplasms, Neoplasm Metastasis, Neoplasms, Oropharyngeal Neoplasms, Recurrence

NCT03581786 2025-09-02

The Efficacy and Safety Study of TORIPALIMAB INJECTION Combined With Chemotherapy for Nasophapyngeal Cancer

Phase 3 Completed

289 enrolled 32 charts 2 FDA

Recurrence

NCT07022002 2025-08-03

SSGJ-705 Monotherapy and Combination Therapy in Advanced HER2-Expressing Solid Tumors

Phase 2 Recruiting

340 enrolled

Neoplasms, Recurrence

NCT07098949 2025-08-01

Acupuncture Combined With Chemotherapy for Gastric Cancer After Surgery

Phase NA Not yet recruiting

346 enrolled

Gastrointestinal

Recurrence, Stomach Neoplasms